Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes

OBJECTIVE: To explore whether treatment with pioglitazone was associated with risk of incident cancer at the 10 most common sites (prostate, female breast, lung/bronchus, endometrial, colon, non-Hodgkin lymphoma [NHL], pancreas, kidney/renal pelvis, rectal, and melanoma). RESEARCH DESIGN AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrara, Assiamira, Lewis, James D., Quesenberry, Charles P., Peng, Tiffany, Strom, Brian L., Van Den Eeden, Stephen K., Ehrlich, Samantha F., Habel, Laurel A.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064052/
https://www.ncbi.nlm.nih.gov/pubmed/21447664
http://dx.doi.org/10.2337/dc10-1067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064052/
https://www.ncbi.nlm.nih.gov/pubmed/21447664
http://dx.doi.org/10.2337/dc10-1067

Ejemplares similares